Business Wire

DEKA Laser and New York’s Romeo & Juliette: A Global Partnership for Advanced Epilation on Fifth Avenue

Share

DEKA Laser, global leader in medical laser technologies, proudly announces its new and prestigious partnership with Romeo & Juliette Hair Removal, the renowned center specialized in permanent hair removal located on world-famous Fifth Avenue in New York City. Thanks to this exclusive collaboration, Romeo & Juliette will become another global reference center for DEKA training on laser hair removal, with particular attention to the Again PRO Series line of equipment, and will host the innovative DEKA Epil Academy, an academy dedicated to the training and sharing of advanced hair removal treatment protocols.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241204652458/en/

Located on one of the most elegant and most renowned avenues in the world, Romeo & Juliette Hair Removal is considered true excellence in the aesthetic and medical realm, and is frequented by celebrities, top models and prominent sports personalities. This new international training center will become the reference point for physicians and specialists from all over the world who wish to train on the most innovative and effective laser hair removal protocols, in particular for the treatment of all phototypes.

“The collaboration with Romeo & Juliette represents a significant achievement for DEKA”, says Paolo Salvadeo, DEKA Laser’s CEO. “This partnership allows us to take our quality and innovation standards to one of the most iconic and prestigious locations in the world, making the training experience unique in its type. I am proud to be able to give life to this project, which will contribute to the growth and diffusion of the Again PRO technology and our advanced hair removal protocols.

Also Chris Karavolas, Director of the Romeo & Juliette Center, expresses his enthusiasm for this new phase: “We are thrilled to cooperate with DEKA, a subsidiary of the El.En. Group, an absolute reference company in the world of laser technology. This synergy will allow us to offer cutting-edge treatments to our clients, constantly optimizing the protocols for every skin type. For us working side by side with DEKA and El.En. Group represents a unique growth and development opportunity”.

Chris Karavolas, with over twenty years of experience in the hair removal field, will work closely with the DEKA team to perfect the treatment protocols for every skin type, contributing to positioning Romeo & Juliette and DEKA Laser as global leaders in the sector.

The DEKA Epil Academy will position itself as a center of excellence in the hair removal training, attracting professionals the world over toward the famous Fifth Avenue, a meeting place of innovation, beauty and technology.

https://dekalaser.com/products/again-pro/
https://www.romeojuliettelaserhairremoval.com/

Information on DEKA

DEKA is a subsidiary of the EL.EN. multinational Group which has been the leader in the laser work for 40 years.

This Italian company, headquartered in Florence, has its roots in a culture whose dominant characteristic is excellence of thought. Thanks to its priceless cultural heritage and its unique historical background, DEKA enshrines a promise of universal value in its vision: Transforming each scientific discovery into a solid benefit for physicians and patients and translate each technological innovation into ongoing improvement in its product and services range to ameliorate the quality of people’s lives.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241204652458/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting konsoliderer sit udbud inden for digital transformation med tilføjelsen af Internet & Idee22.1.2026 14:04:00 CET | Pressemeddelelse

Andersen Consulting indgår en samarbejdsaftale med Internet & Idee, et italiensk digitalt konsulentbureau, og styrker dermed sin evne til at levere integrerede, teknologidrevne løsninger. Internet & Idee blev stiftet i 1998 og specialiserer sig i digital strategi, softwareudvikling, test og kvalitetssikring, e-handel og mobile løsninger. Virksomheden opererer inden for to kerneområder: It-konsulentydelser og egne SaaS-produkter, herunder værktøjer til kreditstyring og cybersikkerhed. Med dyb ekspertise inden for bankvæsen, forsikring, kreditstyring og logistik for e-handel kombinerer Internet & Idee brancheindsigt med teknisk innovation med henblik på at drive forretningsresultater. "Dette samarbejde giver os mulighed for at anvende vores digitale ekspertise og branchekendskab i større skala," udtaler Carlo Stumpo, administrerende direktør for Internet & Idee. "Sammen med Andersen Consulting kan vi levere mere målrettede og effektive løsninger til kunder, der står over for komplekse ud

Overall Survival Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer22.1.2026 14:00:00 CET | Press release

Data demonstrate a 35 percent reduction in the risk of death Both dual primary endpoints (progression-free and overall survival) were met, without the need for biomarker selection and without increased safety burden Relacorilant’s New Drug Application (NDA) is under review by the U.S. Food and Drug Administration (FDA) as a treatment for patients with platinum-resistant ovarian cancer with a Prescription Drug User Fee Act (PDUFA) target action date of July 11, 2026 Relacorilant’s Marketing Authorization Application (MAA) for patients with platinum-resistant ovarian cancer is also under review by the European Medicines Agency (EMA) Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that ROSELLA, the company’s pivotal Phase 3 trial of relacorilant plus nab-paclitax

ExaGrid Announces All Flash/SSD Tiered Backup Storage Solution22.1.2026 14:00:00 CET | Press release

ExaGrid’s new solution offers the fastest, most scalable, and most secure backups in the industry ExaGrid®, the industry’s only Tiered Backup Storage solution with AI-Powered Retention Time-Lock (RTL) that includes a non-network-facing tier (tiered air gap), Auto Detect & Guard, delayed deletes and immutability for ransomware recovery, today announced that it is shipping an All Flash/SSD backup storage solution with a unique front-end Landing Zone and non-network-facing Repository Tier (tiered air gap) that stores all backup retention using advanced data deduplication. The new SSD appliances ship with ExaGrid software version 8. ExaGrid’s unique Landing Zone and scale-out architecture allow for significantly faster backups and restores, as well as scalability as data grows, versus other SSD products such as Dell Data Domain inline deduplication appliances with SSD or straight SSD from Pure Storage. Due to three years of software work and the extremely fast performance of SSD, ExaGrid’s

Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis22.1.2026 14:00:00 CET | Press release

New Trailmaker functionality integrates immune repertoire and whole transcriptome data to deliver rapid, publication-ready insights Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and whole transcriptome analysis workflow in its data analysis platform, Trailmaker™. The new functionality complements Parse’s existing portfolio of Evercode immune products to enable a full end-to-end workflow for researchers. Immunologists have lacked an integrated, purpose-built platform capable of connecting immune repertoire data with whole transcriptome single cell insights. As a result, interpreting clonal behavior, understanding functional cell states, and drawing meaningful biological conclusions has often required stitching together fragmented tools, custom code, or inconsistent visualization approaches. The new Trailmaker functionality directly addresses these challenges by provi

AMGTA Announces EOS as New Principal Member and Appoints Björn Hannappel to Board of Directors22.1.2026 13:59:00 CET | Press release

The Additive Manufacturer Green Trade Association (AMGTA) today announced that EOS has elevated its longstanding participation in the association to Principal Member. As part of this expanded leadership role, Björn Hannappel, Head of Sustainability at EOS, has joined the AMGTA Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121601881/en/ Björn Hannappel, Head of Sustainability at EOS, has joined the AMGTA Board of Directors. Principal Membership represents AMGTA’s highest level of engagement and is reserved for organizations demonstrating sustained leadership, strategic alignment, and a commitment to advancing sustainable and resilient manufacturing practices globally. As a Principal Member, EOS will take on an expanded role in shaping AMGTA’s strategic direction, governance, and industry collaboration initiatives. EOS is a world-leading technology supplier in the field of commercial 3D printing of meta

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye